We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$50.1M
Cap. Flow
+$54.6M
Cap. Flow %
34.86%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
1
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$74.3M
2
CGEM icon
Cullinan Oncology
CGEM
+$14M
3
IRON icon
Disc Medicine
IRON
+$1.89M

Top Sells

Rank Stock Value
1
HIMS icon
Hims & Hers Health
HIMS
+$26.1M
2
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$9.38M
3
ME
23andMe Holding Co
ME
+$124K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALMS
1
Alumis Inc
ALMS
$3.69B
$74.3M 47.43%
+5,584,887
New +$74.3M
HIMS icon
2
Hims & Hers Health
HIMS
$6.26B
$35.5M 22.68%
1,759,314
-1,567,469
-47% -$26.1M
CGON icon
3
CG Oncology
CGON
$6.44B
$21.9M 13.96%
692,550
– –
IRON icon
4
Disc Medicine
IRON
$3.03B
$13.5M 8.61%
299,069
+55,556
+23% +$1.89M
CGEM icon
5
Cullinan Oncology
CGEM
$1.08B
$11.5M 7.33%
+657,905
New +$14M
ME
6
DELISTED
23andMe Holding Co
ME
– –
-11,610
Closed -$124K
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-3,525,957
Closed -$9.38M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q2 2024 Portfolio in Review

As of Q2 2024, Foresite Capital Management V held 7 positions worth $157M, up 47% from $107M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V deployed $54.6M of net new capital in Q2 2024, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Alumis Inc: 5,584,887 shares worth $74.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Hims & Hers Health, an estimated $26.1M trimmed.

  • Foresite Capital Management V's largest Q2 2024 buy was Alumis Inc: 5,584,887 shares worth $74.3M.
  • Foresite Capital Management V added most to Disc Medicine in Q2 2024, an estimated $1.89M increase.
  • Foresite Capital Management V's biggest Q2 2024 reduction was Hims & Hers Health, cutting an estimated $26.1M.
  • Foresite Capital Management V fully exited Kinnate Biopharma Inc. Common Stock in Q2 2024, selling an estimated $9.38M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $157M portfolio in Q2 2024.
  • Foresite Capital Management V opened 2 new positions and closed 2 in Q2 2024.
  • Foresite Capital Management V's portfolio value rose 47% quarter-over-quarter to $157M.

Based on Foresite Capital Management V's 13F filing for Q2 2024, filed 13 Aug 2024.